Literature DB >> 20529846

Type II collagen expression is regulated by tissue-specific miR-675 in human articular chondrocytes.

Katarzyna A Dudek1, Jérôme E Lafont, Aida Martinez-Sanchez, Christopher L Murphy.   

Abstract

miRNAs have been shown to be essential for normal cartilage development in the mouse. However, the role of specific miRNAs in cartilage function is unknown. Using rarely available healthy human chondrocytes (obtained from 8 to 50 year old patients), we detected a most highly abundant primary miRNA H19, whose expression was heavily dependent on cartilage master regulator SOX9. Across a range of murine tissues, expression of both H19- and H19-derived miR-675 mirrored that of cartilage-specific SOX9. miR-675 was shown to up-regulate the essential cartilage matrix component COL2A1, and overexpression of miR-675 rescued COL2A1 levels in H19- or SOX9-depleted cells. We thus provide evidence that SOX9 positively regulates COL2A1 in human articular chondrocytes via a previously unreported miR-675-dependent mechanism. This represents a novel pathway regulating cartilage matrix production and identifies miR-675 as a promising new target for cartilage repair.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20529846      PMCID: PMC2915673          DOI: 10.1074/jbc.M110.111328

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  Transcription and processing of human microRNA precursors.

Authors:  Bryan R Cullen
Journal:  Mol Cell       Date:  2004-12-22       Impact factor: 17.970

2.  The new collagen gene COL27A1 contains SOX9-responsive enhancer elements.

Authors:  Elizabeth Jenkins; Jennie B Moss; James M Pace; Laura C Bridgewater
Journal:  Matrix Biol       Date:  2005-04-22       Impact factor: 11.583

Review 3.  The diverse functions of microRNAs in animal development and disease.

Authors:  Wigard P Kloosterman; Ronald H A Plasterk
Journal:  Dev Cell       Date:  2006-10       Impact factor: 12.270

4.  Dicer-dependent pathways regulate chondrocyte proliferation and differentiation.

Authors:  Tatsuya Kobayashi; Jun Lu; Bradley S Cobb; Stephen J Rodda; Andrew P McMahon; Ernestina Schipani; Matthias Merkenschlager; Henry M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-31       Impact factor: 11.205

5.  Control of stress-dependent cardiac growth and gene expression by a microRNA.

Authors:  Eva van Rooij; Lillian B Sutherland; Xiaoxia Qi; James A Richardson; Joseph Hill; Eric N Olson
Journal:  Science       Date:  2007-03-22       Impact factor: 47.728

6.  The imprinted H19 noncoding RNA is a primary microRNA precursor.

Authors:  Xuezhong Cai; Bryan R Cullen
Journal:  RNA       Date:  2007-01-19       Impact factor: 4.942

7.  Hypoxia promotes the differentiated human articular chondrocyte phenotype through SOX9-dependent and -independent pathways.

Authors:  Jérôme E Lafont; Sonia Talma; Christine Hopfgarten; Christopher L Murphy
Journal:  J Biol Chem       Date:  2007-12-12       Impact factor: 5.157

8.  MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb.

Authors:  Changchun Xiao; Dinis Pedro Calado; Gunther Galler; To-Ha Thai; Heide Christine Patterson; Jing Wang; Nikolaus Rajewsky; Timothy P Bender; Klaus Rajewsky
Journal:  Cell       Date:  2007-10-05       Impact factor: 41.582

9.  Mechanisms of disease: role of chondrocytes in the pathogenesis of osteoarthritis--structure, chaos and senescence.

Authors:  Thomas Aigner; Stefan Söder; Pia M Gebhard; Audrey McAlinden; Jochen Haag
Journal:  Nat Clin Pract Rheumatol       Date:  2007-07

10.  Hypoxia-inducible factor 2alpha is essential for hypoxic induction of the human articular chondrocyte phenotype.

Authors:  Jérôme E Lafont; Sonia Talma; Christopher L Murphy
Journal:  Arthritis Rheum       Date:  2007-10
View more
  69 in total

Review 1.  MicroRNA control of bone formation and homeostasis.

Authors:  Jane B Lian; Gary S Stein; Andre J van Wijnen; Janet L Stein; Mohammad Q Hassan; Tripti Gaur; Ying Zhang
Journal:  Nat Rev Endocrinol       Date:  2012-01-31       Impact factor: 43.330

Review 2.  Osteoarthritis: a disease of the joint as an organ.

Authors:  Richard F Loeser; Steven R Goldring; Carla R Scanzello; Mary B Goldring
Journal:  Arthritis Rheum       Date:  2012-03-05

Review 3.  The Role of the Microenvironment in Controlling the Fate of Bioprinted Stem Cells.

Authors:  Lauren N West-Livingston; Jihoon Park; Sang Jin Lee; Anthony Atala; James J Yoo
Journal:  Chem Rev       Date:  2020-06-19       Impact factor: 60.622

Review 4.  MicroRNAs as novel regulators of stem cell fate.

Authors:  Eunhyun Choi; Eunmi Choi; Ki-Chul Hwang
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

Review 5.  Epigenetic mechanisms underlying the aberrant catabolic and anabolic activities of osteoarthritic chondrocytes.

Authors:  Mingcai Zhang; Brian Egan; Jinxi Wang
Journal:  Int J Biochem Cell Biol       Date:  2015-05-12       Impact factor: 5.085

6.  A microRNA signature associated with chondrogenic lineage commitment.

Authors:  Behnaz Bakhshandeh; Masoud Soleimani; Seyed Hassan Paylakhi; Nasser Ghaemi
Journal:  J Genet       Date:  2012-08       Impact factor: 1.166

7.  Differential miRNA expression profiles between the first and third trimester human placentas.

Authors:  Yang Gu; Jingxia Sun; Lynn J Groome; Yuping Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-26       Impact factor: 4.310

Review 8.  Regulatory mechanisms for the development of growth plate cartilage.

Authors:  Toshimi Michigami
Journal:  Cell Mol Life Sci       Date:  2013-05-04       Impact factor: 9.261

9.  miR-1247 functions by targeting cartilage transcription factor SOX9.

Authors:  Aida Martinez-Sanchez; Chris L Murphy
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

Review 10.  Long noncoding RNAs: a new regulatory code in osteoarthritis.

Authors:  Xiao Cen; Xin-Qi Huang; Wen-Tian Sun; Qing Liu; Jun Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.